Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New filter on dialysis machines could scratch itch and fatigue for kidney patients

NCT ID NCT07522008

Symptom relief Sponsor: Azienda Ospedaliera Brotzu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adding a blood-filtering step called hemoadsorption to regular dialysis can help people with kidney failure who still have bothersome symptoms like itching, tiredness, and trouble sleeping. Researchers will follow 120 adults for 6 months, tracking how their symptoms and quality of life change. It is an observational registry, meaning doctors use the filter as part of normal care, and the study just watches what happens.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hemoadsorption (a blood-filtering device added to standard dialysis)
What this could lead to
If successful, this could show that adding hemoadsorption to dialysis helps reduce stubborn symptoms like itching and fatigue, improving quality of life for kidney patients.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by other factors. It is small (120 people) and early, so it cannot prove the treatment works definitively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients with end-stage kidney disease (CKD stage 5D) receiving maintenance hemodialysis in participating dialysis centers. Eligible participants are individuals with a stable dialysis regimen who report at least one clinically relevant uremic symptom at baseline, as assessed by the Dialysis Symptom Index. Patients are enrolled during routine clinical care and followed prospectively after initiation of hemodialysis combined with hemoadsorption, in accordance with local standard practice.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) with end-stage kidney disease (CKD stage 5D) on maintenance hemodialysis. * Stable hemodialysis treatment for at least 3 months prior to enrollment. * Presence of at least one moderate-to-severe uremic symptom, as identified by the Dialysis Symptom Index at screening. * Planned treatment with hemodialysis combined with hemoadsorption according to local clinical practice. * Ability to provide written informed consent. Exclusion Criteria: * Acute illness, active infection, or hospitalization within 4 weeks prior to enrollment. * Planned kidney transplantation within the study follow-up period. * Life expectancy less than 6 months due to non-renal comorbid conditions. * Inability to complete patient-reported outcome questionnaires. * Participation in another interventional clinical study that could interfere with study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease 5D are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome end stage renal failure uremia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease 5D Uremia; chronic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • S.C.D.U. Nefrologia, Dialisi e Trapianto ARNAS G.Brotzu, Cagliari

    RECRUITING

    Cagliari, Italy, 09100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.